NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.19
0.02 (1.71%)
At close: Aug 15, 2025, 2:39 PM
13F Institute Ownership
Total Institutes of 11 in NeuroSense Therapeutics reduced their positions with a decrease of 2 investors compared to the previous quarter. A reduction of 451.62K shares, as total invested capital declined by $595.07K with ownership percentage dropping from 3.58% to 0.84%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Morgan Stanley | 0.22% | 50.5K | -50.77% | 46.96K | < 0.01% | May 15, 2025 |
| Meitav Investment House Ltd | 0.17% | 40K | +0.00% | 37.2K | < 0.01% | May 12, 2025 |
| Xtx Topco Ltd | 0.15% | 33.71K | -19.55% | 31.02K | < 0.01% | May 08, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.